Companies / Forma Therapeutics Holdings, Inc.
Forma Therapeutics Holdings, Inc.
FMTXFTMXCIK 1538927
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | Ra Capital Management, LLC Director | Other Other (per filing) | Common Stock | $15.19M | +542K +7.79% | 7,500,226 | low |
| Feb 23, 2022 | Lee Frank D. CEO | Sell Open-market sale | Common Stock | $175.8K | -18K -18.39% | 79,769 | medium |
| Apr 8, 2022 | Kelly Patrick F. Executive | Exercise Option exercise | Common Stock | $75.8K | +15K +16.69% | 104,884 | low |
| Feb 23, 2022 | Shegog Todd Executive | Sell Open-market sale | Common Stock | $55.6K | -6K -19.95% | 22,813 | low |
| Feb 23, 2022 | Kelly Patrick F. Executive | Sell Open-market sale | Common Stock | $51.3K | -5K -7.48% | 64,884 | low |
| Feb 23, 2022 | Wadlinger Mary E. Executive | Sell Open-market sale | Common Stock | $45.8K | -5K -3.36% | 134,521 | low |
| Feb 23, 2022 | Potts Jeannette Executive | Sell Open-market sale | Common Stock | $45.7K | -5K -17.28% | 22,358 | low |
| Feb 23, 2022 | Lesser Brian Andrew Executive | Sell Open-market sale | Common Stock | $37.5K | -4K -17.90% | 17,593 | low |